Combination nivolumab with transcatheter arterial chemoembolization for clinical remission of small cell lung cancer: A case report
from Thoracic Cancer
From March 8:
The outcome of small cell lung cancer (SCLC) patients is poor because rapid metastasis develops after first-line chemotherapy and few drugs are available for second-line chemotherapy. The median survival rate has not significantly changed in recent years.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063